Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors

Figure 4

Binding orientations of hit compounds: (a) Entinostat, (b) NSC108392, (c) NSC127064, (d) NSC110782, (e) NSC748337, (f) MFCD01935795, (g) MFCD00830779, (h) MFCD00661790, and (i) MFCD00124221 in the active site of 3MAX-A with hydrogen bond interactions.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)